General - Press Releases

Date	Title	Company
03-Feb-2023	Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials	Businesswire
03-Feb-2023	Ambrx Biopharma Strengthens Clinical Leadership with Appointment of Sandra Aung, Ph.D. as Head of Clinical Development	Businesswire
03-Feb-2023	New Talk About It Resources Aim to Accelerate Integration of Mental Health into Quality Cancer Care	Businesswire
03-Feb-2023	Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma	Businesswire
03-Feb-2023	KalVista Pharmaceuticals to Present at SVB Securities Global Biopharma Conference	Businesswire
03-Feb-2023	North America Gastrointestinal Therapeutics Market Research Report 2022 - ResearchAndMarkets.com	Businesswire
03-Feb-2023	Global Needle Free Injection System Market Report 2022: Trends, Opportunities and Competitive Analysis 2021-2027 - ResearchAndMarkets.com	Businesswire
03-Feb-2023	Last Chance to Register for This 2 Day Analytical Method Validation, Verification and Transfer Course: February 9-10, 2023 - ResearchAndMarkets.com	Businesswire
03-Feb-2023	Global Proteomics Market Report 2022 to 2030 - Featuring Agilent Technologies, Bio-Rad Laboratories, Bruker and Siemens Among Others - ResearchAndMarkets.com	Businesswire
03-Feb-2023	Insights on the Internet of Medical Things (IoMT) Global Market to 2028: North America is Estimated to Dominate the Market - ResearchAndMarkets.com	Businesswire
03-Feb-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
03-Feb-2023	Dexlevo’s GOURI Symposium and Brand Event at IMCAS 2023	Businesswire
03-Feb-2023	MaaT Pharma Receives U.S. FDA Response Outlining Path Forward for Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease and Reports Cash and Revenues for Fourth Quarter 2022	Businesswire
03-Feb-2023	Celyad Oncology Provides Fourth Quarter 2022 Business Update and 2023 Outlook	Businesswire
03-Feb-2023	Murchinson Issues Letter to Fellow Shareholders Regarding the Urgent Need for Boardroom Change at Nano Dimension	Businesswire
03-Feb-2023	Fate Therapeutics, Inc. (FATE) Shareholder Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Fate Therapeutics, Inc.	Businesswire
03-Feb-2023	Takeda renforce sa croissance à long terme grâce à la promotion de son pipeline et à deux acquisitions ciblées ; et présente une nouvelle performance solide au T3 2022	Businesswire
03-Feb-2023	Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results	Businesswire
02-Feb-2023	Carbios clôture avec succès le projet CE-PET1 co-financé par l'Etat et opéré par l'ADEME qui a démontré l’application aux textiles de sa technologie de biorecyclage du PET	Businesswire
02-Feb-2023	Carbios successfully concludes CE-PET1 project supported by the French State and operated by ADEME, which demonstrated the application of its PET biorecycling technology to textiles	Businesswire